New York State Common Retirement Fund’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $38.9M | Buy |
|
|||||
|
2025
Q3 | $33.8M | Sell |
|
|||||
|
2025
Q2 | $31.5M | Sell |
|
|||||
|
2025
Q1 | $31.9M | Hold |
|
|||||
|
2024
Q4 | $28.2M | Buy |
|
|||||
|
2024
Q3 | $26.8M | Sell |
|
|||||
|
2024
Q2 | $27.2M | Buy |
|
|||||
|
2024
Q1 | $29.6M | Sell |
|
|||||
|
2023
Q4 | $25.8M | Sell |
|
|||||
|
2023
Q3 | $19.2M | Sell |
|
|||||
|
2023
Q2 | $18.3M | Sell |
|
|||||
|
2023
Q1 | $26.6M | Sell |
|
|||||
|
2022
Q4 | $31.2M | Sell |
|
|||||
|
2022
Q3 | $28.7M | Buy |
|
|||||
|
2022
Q2 | $25.4M | Sell |
|
|||||
|
2022
Q1 | $34.8M | Buy |
|
|||||
|
2021
Q4 | $38.5M | Sell |
|
|||||
|
2021
Q3 | $53.1M | Buy |
|
|||||
|
2021
Q2 | $37.4M | Buy |
|
|||||
|
2021
Q1 | $35.6M | Buy |
|
|||||
|
2020
Q4 | $45.2M | Sell |
|
|||||
|
2020
Q3 | $44.4M | Buy |
|
|||||
|
2020
Q2 | $37.6M | Sell |
|
|||||
|
2020
Q1 | $30.7M | Buy |
|
|||||
|
2019
Q4 | $35.8M | Sell |
|
|||||
|
2019
Q3 | $25.5M | Sell |
|
|||||
|
2019
Q2 | $30.7M | Buy |
|
|||||
|
2019
Q1 | $27.4M | Sell |
|
|||||
|
2018
Q4 | $14.6M | Buy |
|
|||||
|
2018
Q3 | $11.4M | Buy |
|
|||||
|
2018
Q2 | $8.03M | Buy |
|
|||||
|
2018
Q1 | $6.73M | Buy |
|